Literature DB >> 29050906

Hospital readmissions related to Clostridium difficile infection in the United States.

Abhishek Deshpande1, Chaitanya Pant2, Mojtaba Olyaee3, Curtis J Donskey4.   

Abstract

Using a national readmissions database, we report a significant burden of Clostridium difficile-associated readmissions in the United States manifested as a high rate of rehospitalizations and substantial hospital stays and costs.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.

Entities:  

Keywords:  C difficile; readmission

Mesh：

Year:  2017        PMID： 29050906     DOI： 10.1016/j.ajic.2017.08.043

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  5 in total

1.  Risk Factors for Hospital Readmission for Clostridioides difficile Infection: A Statewide Retrospective Cohort Study.

Authors:  Gregorio Benitez; Fadi Shehadeh; Markos Kalligeros; Evangelia K Mylona; Quynh-Lam Tran; Ioannis M Zacharioudakis; Eleftherios Mylonakis
Journal:  Pathogens       Date:  2022-05-08

2.  Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in Mice.

Authors:  Mark E Obrenovich; George E Jaskiw; Thriveen Sankar Chittoor Mana; Christina P Bennett; Jennifer Cadnum; Curtis J Donskey
Journal:  Pathog Immun       Date:  2019-11-14

3.  Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization.

Authors:  Elizabeth Scaria; W Ryan Powell; Jen Birstler; Oguzhan Alagoz; Daniel Shirley; Amy J H Kind; Nasia Safdar
Journal:  BMC Infect Dis       Date:  2020-10-16       Impact factor: 3.090

4.  Changes in the Serum Metabolome of Patients Treated With Broad-Spectrum Antibiotics.

Authors:  George E Jaskiw; Mark E Obrenovich; Sirisha Kundrapu; Curtis J Donskey
Journal:  Pathog Immun       Date:  2020-12-29

5.  Impact of the use of local fidaxomicin treatment algorithms for managing Clostridium difficile infection in hospitalized patients in southeastern United States.

Authors:  Jonathan C Cho; Sandy J Estrada; Jamie J Kisgen; Angelina Davis; Laura Puzniak
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-10-11       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.